These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 25284039
1. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix. Kong TW, Son JH, Chang SJ, Paek J, Lee Y, Ryu HS. Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039 [Abstract] [Full Text] [Related]
2. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer. Park JY, Lee SM, Yoo CW, Kang S, Park SY, Seo SS. Gynecol Oncol; 2007 Oct; 107(1):39-44. PubMed ID: 17582476 [Abstract] [Full Text] [Related]
3. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Campo E, Pahisa J, Ordi J. Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934 [Abstract] [Full Text] [Related]
4. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization. Park JY, Lee KH, Dong SM, Kang S, Park SY, Seo SS. Gynecol Oncol; 2008 Mar; 108(3):549-54. PubMed ID: 18177929 [Abstract] [Full Text] [Related]
5. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway. Vintermyr OK, Iversen O, Thoresen S, Quint W, Molijn A, de Souza S, Rosillon D, Holl K. Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451 [Abstract] [Full Text] [Related]
6. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia. Spinillo A, Dominoni M, Boschi AC, Cesari S, Fiandrino G, Gardella B. Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069 [Abstract] [Full Text] [Related]
7. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization]. Niu XY, Feng YK. Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452 [Abstract] [Full Text] [Related]
8. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP. Mo LZ, Song HL, Wang JL, He Q, Qiu ZC, Li F. Asian Pac J Cancer Prev; 2015 Mar; 16(10):4297-302. PubMed ID: 26028089 [Abstract] [Full Text] [Related]
9. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Jain S, Tseng CJ, Horng SG, Soong YK, Pao CC. Gynecol Oncol; 2001 Jul; 82(1):177-80. PubMed ID: 11426982 [Abstract] [Full Text] [Related]
10. Predictive factors from cold knife conization for residual cervical intraepithelial neoplasia in subsequent hysterectomy. Moore BC, Higgins RV, Laurent SL, Marroum MC, Bellitt P. Am J Obstet Gynecol; 1995 Aug; 173(2):361-6; discussion 366-8. PubMed ID: 7645609 [Abstract] [Full Text] [Related]
11. Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses. Maluf PJ, Adad SJ, Murta EF. Tumori; 2004 Aug; 90(5):473-7. PubMed ID: 15656332 [Abstract] [Full Text] [Related]
12. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Chao A, Lin CT, Hsueh S, Chou HH, Chang TC, Chen MY, Lai CH. Am J Obstet Gynecol; 2004 Apr; 190(4):1046-51. PubMed ID: 15118639 [Abstract] [Full Text] [Related]
13. Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia. Ruano Y, Torrents M, Ferrer FJ. Eur J Gynaecol Oncol; 2015 Apr; 36(3):245-51. PubMed ID: 26189247 [Abstract] [Full Text] [Related]
14. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M, Terzano P, Santini D, Cristiani P, Syrjänen S, Syrjänen K. Gynecol Oncol; 2003 Aug; 90(2):358-65. PubMed ID: 12893200 [Abstract] [Full Text] [Related]
15. The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins. Song SH, Park HM, Eom DW, Lee JK, Lee NW, Kim AR, Hur JY, Lee KW, Park YK, Saw HS. Int J Gynecol Cancer; 2007 Aug; 17(4):858-67. PubMed ID: 17367326 [Abstract] [Full Text] [Related]
17. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Lin CT, Tseng CJ, Lai CH, Hsueh S, Huang KG, Huang HJ, Chao A. Am J Obstet Gynecol; 2001 Apr; 184(5):940-5. PubMed ID: 11303202 [Abstract] [Full Text] [Related]
18. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia. Fambrini M, Penna C, Pieralli A, Bussani C, Fallani MG, Andersson KL, Scarselli G, Marchionni M. Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129 [Abstract] [Full Text] [Related]